fda compounding semaglutide crackdown 2025 news New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA steps up crackdown on

Every protocol starts with a consultation, uses 503A pharmacy sourcing, and includes provider monitoring throughout

Obesity development in both rodents and humans is associated with accumulation of adipose tissue macrophages (ATMs), which propagate chronic local and systemic inflammatory responses and thereby contribute to insulin resistance (51)

Nothing shifted in transit

the new blood vessels could inadvertently feed microscopic cancer cells

Be ready to discuss your weight loss goals and lifestyle habits

It kills or limits pathogens that trigger genital tract inflammation and it modulates host immune responses to prevent excessive damage